cdk4 glutathione Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities Breaking Cancer's Momentum: CDK4/6 Inhibitors
Breaking Cancer's Momentum: CDK4 6 Inhibitors and the Promise of Combination Therapy PMC Inhibition of METTL14 overcomes CDK4 6 inhibitor resistance driven by METTL14 m6A E2F1 axis in ER positive breast cancer Journal of Nanobiotechnology Springer Nature Link Rb and FZR1 Cdh1 determine CDK4 6 cyclin D requirement in C. elegans and human cancer cells Nature Communications Inhibition of Mitochondrial Antioxidant Defense and CDK4 6 in Mesothelioma MYC induces CDK4 6 inhibitors resistance by promoting pRB1 degradation Nature Communications Cyclin D Cdk4,6 Drives Cell Cycle Progression via the Retinoblastoma Protein's C Terminal Helix: Molecular Cell
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





